MI Arrowhead Publishers and Conferences
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Molecular Interventions 8:277-280, (2008)
© American Society for Pharmacology and Experimental Therapeutics
10.1124/mi.8.6.4
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by van Rijn, R. M.
Right arrow Articles by Whistler, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by van Rijn, R. M.
Right arrow Articles by Whistler, J. L.

Viewpoint

The Only Way Is Up: Preventing Opioid Tolerance by Promoting Cell Surface Expression of MOR-DOR Heterodimers?

Richard M. van Rijn and Jennifer L. Whistler

Ernest Gallo Clinic and Research Center, Department of Neurology, University of California San Francisco, Emeryville, California

SUMMARY

The development of morphine tolerance is a complicated process likely involving many different factors. Both µ (MOR) and {delta} (DOR) opi-oid receptors are known to influence morphine tolerance. Significantly, the role of both receptors appears to change during the acquisition of tolerance, and for both these receptors, regulated receptor trafficking may influence these changes. Morphine does not induce substantial endocytosis and recycling of MORs but appears to increase surface expression of DOR, which, under many conditions, is not efficiently transported to the cell surface. A recent report demonstrates that members of the family of Receptor Transporter Proteins increase surface expression of MOR-DOR heterodimers. The implications of these findings with regard to morphine tolerance are discussed.




This article has been cited by other articles:


Home page
Mol. Interv.Home page
M. A. Simmons
Let's Go Rafting: Ligand Functional Selectivity May Depend on Membrane Structure
Mol. Interv., December 1, 2008; 8(6): 281 - 283.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ASPET Journals Pharmacological Reviews Drug Metabolism and Disposition
Molecular Interventions Molecular Pharmacology J Pharmacology and Exp Therapeutics
Copyright © 2008 by the American Society for Pharmacology and Experimental Therapeutics.